Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-816-9 | CAS number: 74-86-2
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Non-human information
In vitro data
The key studies are considered to be a bacterial mutation assay (Harlan Laboratories, 2010a), a mammalian cell gene mutation assay (Harlan Laboratories, 2010b) and a mammalian cell cytogenetic assay (Harlan Laboratories, 2010c). These are three recognised core assay types for investigating mutation in vitro.
Acetylene was tested in an Ames plate assay modified to allow exposure to a gaseous material (Harlan Labortaories, 2010a). S. typhimurium strains TA1535, TA1537, TA98 and TA100, together with E.Coli strain WP2uvrA were used with exposures carried out both with and without auxiliary metabolic activation (S9). A range of doses was used from 0.5 to 50% atmospheres. Acetylene was negative in this assay.
In the mammalian cell gene mutation assay (Harlan Laboratories, 2010b), mouse lymphoma (L5178Y) cells were exposed to acetylene in a contained system in both the absence and presence of S9, again at doses up to 50% atmosphere. Exposure times of 4 hours (+/- S9) and 24 hours (-S9) were used. Acetylene was negative in this assay.
In the mammalian cell cytogenetic assay (Harlan Laboratories, 2010c), CHL cells were exposed to acetylene in a contained system in both the absence and presence of S9, at doses up to 1.25% atmosphere. Exposure times of 6 hours (+/- S9) and 24 hours (-S9) were used. Acetylene was negative in this assay, both for endpoints of chromosomal damage and also numerical changes.
In vivo data
There are no in vivo mutagenicity data for acetylene. Acetylene has been examined for mutagenic activity in vitro in a range of recognised core assay types, examining for endpoints of gene mutation, chromosomal damage and chromosomal numerical changes, and was negative in all assays. There are no data to indicate any likely genotoxic activity for acetylene in vivo.
Human information
There is no information indicating any adverse effects of acetylene.
Short description of key information:
Acetylene has been examined for mutagenicity in vitro in a range of recognised core assay types, examining for endpoints of gene mutation, chromosomal damage and chromosomal numerical changes. It has shown negative results in all assays. It is concluded that the available data indicate that acetylene has no significant genotoxicity.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
It is concluded that the available data indicate that acetylene does not warrant classification under CLP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
